Influence of endometrial thickness on pregnancy rates in modified natural cycle frozen‐thawed embryo transfer

Introduction Pregnancy after frozen‐thawed embryo transfer (FET) is a multifactorial process. Although embryo quality is a key factor in determining pregnancy, other factors, including maternal determinants, are also considered to be predictive. Even though an association between endometrial thickne...

Full description

Saved in:
Bibliographic Details
Published inActa obstetricia et gynecologica Scandinavica Vol. 97; no. 7; pp. 808 - 815
Main Authors Groenewoud, Eva R., Cohlen, Ben J., Al‐Oraiby, Amani, Brinkhuis, Egbert A., Broekmans, Frank J. M., Bruin, Jan‐Peter, Dool, Grada, Fleisher, Katrin, Friederich, Jaap, Goddijn, Mariëtte, Hoek, Annemieke, Hoozemans, Diederik A., Kaaijk, Eugenie M., Koks, Caroliene A. M., Laven, Joop S. E., Linden, Paul J. Q., Manger, A. Petra, Rumste, Minouche, Spinder, Taeke, Macklon, Nick S.
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.07.2018
Subjects
Online AccessGet full text
ISSN0001-6349
1600-0412
1600-0412
DOI10.1111/aogs.13349

Cover

More Information
Summary:Introduction Pregnancy after frozen‐thawed embryo transfer (FET) is a multifactorial process. Although embryo quality is a key factor in determining pregnancy, other factors, including maternal determinants, are also considered to be predictive. Even though an association between endometrial thickness measured by transvaginal ultrasound and pregnancy rates has been reported in patients undergoing various assisted reproductive technology treatments, whether endometrial thickness predicts achieving pregnancy after natural cycle FET (NC‐FET) remains unclear. Material and methods In this cohort study, 463 patients allocated to the modified NC‐FET (mNC‐FET) arm of a previously published randomized controlled trial were included. Monitoring in mNC‐FET cycles consisted of regular ultrasound scans, measuring both dominant follicle and endometrial thickness. When the dominant follicle reached a size of 16–20 mm, an injection of human chorionic gonadotrophin was administered and embryo thawing and transfer planned. No minimal endometrial thickness was defined below which transfer was to be deferred. The primary endpoint was ongoing pregnancy rate. Results Overall, the ongoing pregnancy rate per started FET cycle was 12.5%. Multivariate regression analyses showed that embryo quality was the only significant predictor for ongoing pregnancy. Mean endometrial thickness did not differ between patients achieving ongoing pregnancy and those who did not (9.0 vs. 8.8 mm, p = 0.4). Comparable results were obtained with regard to clinical pregnancy, live birth and miscarriage rates. The area under the receiver operator curve was 0.5, indicating little discriminatory value of endometrial thickness. Conclusions Given that endometrial thickness was not found to be predictive of pregnancy after mNC‐FET, cancellation based on endometrial thickness alone may not be justified.
Bibliography:Conflict of interest
E.R.G. received an education grant from Merck Sharpe Dohme (MSD) during the conduct of the present study. B.J.C. reports grants from MSD during the conduct of the study. The Department of Obstetrics and Gynecology of the UMCG received an unrestricted educational grant from Ferring Pharmaceutical BV, the Netherlands. A.H. received a speaker's fee for a post‐graduate degree from MSD pharmaceutical company, outside the submitted work. Grants were received from ZonMW, the Dutch Organization for Health Research and Development. J.S.E.L. reports grants from Ferring, MSD, Organon, Merck‐Serono and Schering‐Plough during the conduct of the study. F.J.M.B. receives monetary compensation as a member of the external advisory board for Merck Serono, consultancy work for Gedeon Richter, educational activities for Ferring BV, research cooperation with Ansh Labs and a strategic cooperation with Roche on automated AMH assay development. N.S.M. reports receiving monetary compensation for external advisory and speaking work for Ferring BV, MSD, Anecova and Merck Serono during the conduct of the study. All reported competing interests are outside the submitted work. There are no other relationships or activities that would appear to have influenced the submitted work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0001-6349
1600-0412
1600-0412
DOI:10.1111/aogs.13349